Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 9, 2005, Pages 3295-3299

  Sakuma, Toshiro ^a   Tanaka, Minoru ^a   Mizota, Atsushi ^a   Inoue, Junji ^a   Pakola, Steve ^b  

^a JUNTENDO UNIVERSITY   (Japan)

^b ThromboGenics NV   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; COLLAGEN FIBRIL; MICROPLASMIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PLASMIN;

A SCAN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTERIOR EYE CHAMBER; ARTICLE; B SCAN; CONTROLLED STUDY; DRUG SAFETY; ELECTRORETINOGRAPHY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RABBIT; RETINA; SCANNING ELECTRON MICROSCOPY; SLIT LAMP; TRANSMISSION ELECTRON MICROSCOPY; VITREOUS BODY DETACHMENT; ANIMAL; CHEMICALLY INDUCED DISORDER; DOSE RESPONSE; DRUG EFFECT; ECHOGRAPHY; INJECTION; METHODOLOGY; PATHOPHYSIOLOGY; SAFETY; VITRECTOMY; VITREOUS BODY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRORETINOGRAPHY; INJECTIONS; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS; PLASMIN; RABBITS; RECOMBINANT PROTEINS; RETINA; SAFETY; VITRECTOMY; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 27244451971     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1517     Document Type: Article

References (28)

1. Sebag J. Age-related differences in the human vitreoretinal interface. Arch Ophthalmol. 1991;109:966-971.
2. Akiba J, Quiroz MA, Trempe CL. Role of posterior vitreous detachment in idiopathic macular holes. Ophthalmology. 1990;97:1619-1655.
3. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes: results of a pilot study. Arch Ophthalmol. 1991;109:654-659.
4. Akiba J, Arzabe CW, Trempe CL. Posterior vitreous detachment and neovascularization in diabetic retinopathy. Ophthalmology. 1990;97:889-891.
5. Kado M, Trempe CL. Role of the vitreous in branch retinal vein occlusion. Am J Ophthalmol. 1988;105:20-24.
6. Sebag J. The Vitreous. Structure, Function, Pathobiology. New York: Springer Verlag; 1989.
7. Faulborn J, Bowald S. Microproliferations in proliferative diabetic retinopathy and their relation to the vitreous. Graefe's Arch Clin Exp Ophthalmol. 1985;223:30-138.
8. Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995;119:752-759.
9. Sebag J. Anomalous PVD-a unifying concept in vitreo-retinal diseases. Graefes Arch Clin Exp Ophthalmol. 2004;242:690-698.
10. Han DP, Abrams GW, Aaberg TM. Surgical excision of the attached posterior hyaloid. Arch Ophthalmol. 1998;106:998-1000.
11. Vander JF, Kleiner R. A method for induction of posterior vitreous detachment during vitrectomy. Retina. 1992;12:172-173.
12. Sebag J. Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol. 1987;225:89-93.
13. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci. 2004;45:641-647.
14. Trese MT. Enzymatic-assisted vitrectomy. Eye. 2002;16:365-368.
15. Gandorfer A, Pringlinger S, Schebitz K, et al. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol. 2002;133:156-159.
16. Gandorfer A, Putz E, Welge-Lussen U, et al. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85:6-10.
17. Verstraeten TC, Chapman C, Hartzer M, et al. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111:849-854.
18. Margherio AR, Margherio RR, Hartzer M, et al. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105:1617-1620.
19. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107:1607-1611.
20. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology. 2001;108:1902-1905.
21. Sakuma T, Tanaka M, Souri M, Ichinose A. Preparation of high-purity and safe autologous plasmin and its clinical application. Nippon Ganka Gakkai Zasshi. 2003;107:709-718.
22. Tanaka M, Qui H. Pharmacological vitrectomy. Semin Ophthalmol. 2000;15:51-61.
23. Sebag J. Pharmacologic vitreolysis (Editorial). Retina. 1998;18:1-3.
24. Bhisitkul RB. Anticipation for enzymatic vitreolysis (Editorial). Br J Ophthalmol. 2001;85:1-3.
25. Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19:55-58.
26. Hesse L, Nebeling B, Schroeder B, Heller G, Kroll P. Induction of posterior vitreous detachment in rabbits by intravitreal injection of tissue plasminogen activator following cryopexy. Exp Eye Res. 2000;70:31-39.
27. Lapchak PA, Araujo DM, Pakola S, et al. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic stroke in rabbits. Stroke. 2002;33:2279-2284.
28. Lapchak PA. Development of thrombolytic therapy for stroke: a perspective. Expert Opin Investig Drugs. 2002;11:1623-1632.